M F Pino1, A Divoux1, A V Simmonds2, S R Smith1,3, L M Sparks1,3. 1. Translational Research Institute for Metabolism and Diabetes, Florida Hospital, Orlando, FL, USA. 2. Center for Specialized Surgery, Florida Hospital, Orlando, FL, USA. 3. Sanford Burnham Prebys Medical Discovery Institute, Orlando, FL, USA.
Abstract
BACKGROUND: Despite successful preclinical testing, 85% of early clinical trials for novel drugs fail. Most futilities originate from molecular mechanisms of the drug(s) tested. It is critically important to develop validated human cell-based model systems in which animal-based research can be translated in order to complement the preclinical in vivo findings prior to implementation of a clinical trial. Obesity is associated with reduced circulating levels of Orexin-A (OX-A) in humans. OX-A increases thermogenesis in rodent brown adipose tissue (AT), yet this phenomenon has not been explored in humans. METHODS: We established a cell-based model system of human brown and white adipocytes and tested the effects of OX-A on thermogenesis. RESULTS: Contrary to published in vivo and in vitro reports in rodents, OX-A treatment alone or in combination with an adrenergic stimulus did neither enhance thermogenesis nor its related transcriptional program in a human in vitro model of brown adipocytes or AT explants. CONCLUSIONS: Translating preclinical findings in human model systems poses a challenge that must be overcome for the development of effective therapeutic compounds and targets.
BACKGROUND: Despite successful preclinical testing, 85% of early clinical trials for novel drugs fail. Most futilities originate from molecular mechanisms of the drug(s) tested. It is critically important to develop validated human cell-based model systems in which animal-based research can be translated in order to complement the preclinical in vivo findings prior to implementation of a clinical trial. Obesity is associated with reduced circulating levels of Orexin-A (OX-A) in humans. OX-A increases thermogenesis in rodent brown adipose tissue (AT), yet this phenomenon has not been explored in humans. METHODS: We established a cell-based model system of human brown and white adipocytes and tested the effects of OX-A on thermogenesis. RESULTS: Contrary to published in vivo and in vitro reports in rodents, OX-A treatment alone or in combination with an adrenergic stimulus did neither enhance thermogenesis nor its related transcriptional program in a human in vitro model of brown adipocytes or AT explants. CONCLUSIONS: Translating preclinical findings in human model systems poses a challenge that must be overcome for the development of effective therapeutic compounds and targets.
Authors: Mark J W Hanssen; Anouk A J J van der Lans; Boudewijn Brans; Joris Hoeks; Kelly M C Jardon; Gert Schaart; Felix M Mottaghy; Patrick Schrauwen; Wouter D van Marken Lichtenbelt Journal: Diabetes Date: 2015-12-30 Impact factor: 9.461
Authors: J Hara; C T Beuckmann; T Nambu; J T Willie; R M Chemelli; C M Sinton; F Sugiyama; K Yagami; K Goto; M Yanagisawa; T Sakurai Journal: Neuron Date: 2001-05 Impact factor: 17.173
Authors: Matthias Johannes Betz; Marc Slawik; Martin E Lidell; Andrea Osswald; Mikael Heglind; Daniel Nilsson; Urs Daniel Lichtenauer; Brigitte Mauracher; Thomas Mussack; Felix Beuschlein; Sven Enerbäck Journal: J Clin Endocrinol Metab Date: 2013-06-06 Impact factor: 5.958
Authors: J Bronský; J Nedvídková; H Zamrazilová; M Pechová; M Chada; K Kotaska; J Nevoral; R Průša Journal: Physiol Res Date: 2006-02-23 Impact factor: 1.881
Authors: Rushita A Bagchi; Bradley S Ferguson; Matthew S Stratton; Tianjing Hu; Maria A Cavasin; Lei Sun; Ying-Hsi Lin; Dianxin Liu; Pilar Londono; Kunhua Song; Maria F Pino; Lauren M Sparks; Steven R Smith; Philipp E Scherer; Sheila Collins; Edward Seto; Timothy A McKinsey Journal: JCI Insight Date: 2018-08-09